Osborne Partners Capital Management, LLC Abbott Laboratories Transaction History

Osborne Partners Capital Management, LLC

$1.75 Billion
Q3 2024

A detailed history of Osborne Partners Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 117,891 shares of ABT stock, worth $13.5 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

117,891

Previous 117,510 0.32%

Holding current value

$13.5 Million

Previous $12.2 Million 10.07%

% of portfolio

0.77%

Previous 0.74%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $38,126 - $45,007	381 Added 0.32%	117,891 $13.4 Million
Q2 2024 Jul 22, 2024	BUY	$100.73 - $112.44 $229,060 - $255,688	2,274 Added 1.97%	117,510 $12.2 Million
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $62,426 - $68,947	570 Added 0.5%	115,236 $13.1 Million
Q4 2023 Jan 22, 2024	BUY	$90.19 - $110.4 $240,356 - $294,216	2,665 Added 2.38%	114,666 $12.6 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $94,479 - $113,359	989 Added 0.89%	112,001 $10.8 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $104,811 - $116,781	1,040 Added 0.95%	111,012 $12.1 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $106,158 - $124,954	1,096 Added 1.01%	109,972 $11.1 Million
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $267,784 - $314,151	-2,817 Reduced 2.52%	108,876 $0
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $95,502 - $110,573	987 Added 0.89%	111,693 $10.8 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $592,720 - $716,409	5,807 Added 5.54%	110,706 $12 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $151,418 - $184,645	1,328 Added 1.28%	104,899 $12.4 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $17,560 - $21,501	-152 Reduced 0.15%	103,571 $14.6 Million
Q3 2021 Oct 25, 2021	BUY	$116.66 - $129.06 $282,083 - $312,067	2,418 Added 2.39%	103,723 $12.3 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $289,547 - $340,838	2,737 Added 2.78%	101,305 $11.7 Million
Q1 2021 Aug 09, 2021	SELL	$108.84 - $128.23 $1.27 Million - $1.5 Million	-11,661 Reduced 10.58%	98,568 $11.8 Million
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $386,926 - $455,857	3,555 Added 3.33%	110,229 $13.2 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $270,165 - $294,402	-2,573 Reduced 2.36%	106,674 $11.7 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $116,841 - $141,894	-1,275 Reduced 1.15%	109,247 $11.9 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $261,180 - $334,278	-3,411 Reduced 2.99%	110,522 $10.1 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $10,679 - $15,616	170 Added 0.15%	113,933 $8.99 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $2.22 Million - $2.47 Million	-28,293 Reduced 19.92%	113,763 $9.88 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $190,687 - $206,764	-2,330 Reduced 1.61%	142,056 $11.9 Million
Q2 2019 Jul 18, 2019	SELL	$72.88 - $85.0 $169,081 - $197,200	-2,320 Reduced 1.58%	144,386 $12.1 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $1.24 Million - $1.49 Million	-18,665 Reduced 11.29%	146,706 $11.7 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $136,758 - $154,927	-2,086 Reduced 1.25%	165,371 $12 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $517,006 - $623,706	-8,502 Reduced 4.83%	167,457 $12.3 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $298,961 - $329,963	-5,193 Reduced 2.87%	175,959 $10.7 Million
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $80,747 - $91,294	-1,435 Reduced 0.79%	181,152 $10.9 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $263,676 - $282,292	-4,912 Reduced 2.62%	182,587 $10.4 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $9.01 Million - $10.1 Million	187,499	187,499 $10 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.

Account

Osborne Partners Capital Management, LLC Abbott Laboratories Transaction History